When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Transtorno da ansiedade social

Última revisão: 21 Oct 2024
Última atualização: 29 May 2024

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • presença de fatores de risco
  • ansiedade antecipatória e preocupação
  • taquicardia
  • hiperventilação
  • sudorese
  • rubor
  • tensão muscular
Detalhes completos

Outros fatores diagnósticos

  • processamento pós-evento
  • vieses de atenção
  • deficits de habilidades sociais
  • choro, acessos de raiva ou "paralisia"
  • mutismo seletivo
Detalhes completos

Fatores de risco

  • comorbidade psiquiátrica (por exemplo, transtornos de ansiedade, humor e uso de substâncias)
  • genética
  • fatores de temperamento
  • estilo de criação
  • transtorno psicológico
  • estressores da vida
  • fatores ambientais
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • diagnóstico clínico
Detalhes completos

Investigações a serem consideradas

  • glicose sanguínea
  • hormônio estimulante da tireoide sérico
  • análise toxicológica (urina e sangue)
Detalhes completos

Algoritmo de tratamento

Contínua

adultos: sem comorbidade

adultos: com comorbidades

crianças e adolescentes

Colaboradores

Autores

Craig N. Sawchuk, PhD
Craig N. Sawchuk

Professor

Department of Psychiatry and Psychology

Mayo Clinic

Rochester

MN

Declarações

CNS declares that he has no competing interests.

Jason P. Veitengruber, MD
Jason P. Veitengruber

Associate Professor

Department of Psychiatry and Behavioral Sciences

University of Washington School of Medicine

Seattle

WA

Declarações

JPV is an author of a reference cited in this topic.

Bunmi O. Olatunji, PhD
Bunmi O. Olatunji

Professor

Department of Psychological Sciences

Vanderbilt University

Nashville

TN

Declarações

BOO declares that he has no competing interests.

Stacy Shaw Welch, PhD
Stacy Shaw Welch

Director

Anxiety and Stress Reduction Center of Seattle

University of Washington

Seattle

WA

Declarações

SSW declares that she has no competing interests.

Revisores

Richard P. Swinson, MD, FRCPC, FRCPsych

Emeritus Professor

Medical Director

Anxiety Treatment and Research Centre

McMaster University and St Joseph’s Hospital

Hamilton

Canada

Declarações

RPS declares that he has no competing interests.

Jeffrey M. Lohr, PhD

Professor

Department of Psychology

University of Arkansas

Fayetteville

AR

Declarações

JML declares that he has no competing interests.

David F. Tolin, PhD

Professor

Institute of Living

Yale University

New Haven

CT

Declarações

DFT declares that he has no competing interests.

David Baldwin, MD

Professor of Psychiatry

University of Southampton

Southampton

UK

Declarações

DB has acted as a consultant for and held research grants from Cephalon, Eli Lilly, GSK, Lundbeck, Organon, Pfizer, Pharmacia, Roche, and Wyeth and has also acted as a consultant to Asahi, AstraZeneca, Grunenthal, Pierre Fabre, Servier, Sumitomo, and Wyeth. He has accepted paid speaking engagements in industry-supported satellite symposia and is co-author of the BAP evidence-based guidelines on the treatment of anxiety disorders. He is also a Medical Patron of Anxiety UK.

O uso deste conteúdo está sujeito ao nosso aviso legal